These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 17572224

  • 1. Gastrointestinal stromal tumors involving the prostate: presentation, course, and therapeutic approach.
    Arce-Lara C, Shah MH, Jimenez RE, Patel VR, Benson DM, Clinton SK, Monk JP.
    Urology; 2007 Jun; 69(6):1209.e5-7. PubMed ID: 17572224
    [Abstract] [Full Text] [Related]

  • 2. Gastrointestinal stromal tumors (GISTs) on prostate needle biopsy: A clinicopathologic study of 8 cases.
    Herawi M, Montgomery EA, Epstein JI.
    Am J Surg Pathol; 2006 Nov; 30(11):1389-95. PubMed ID: 17063078
    [Abstract] [Full Text] [Related]

  • 3. Central nervous system metastases from imatinib mesylate resistant gastrointestinal stromal tumor.
    Gerin F, Baloglu O, Morgan JA, Kesari S.
    J Neurooncol; 2007 Apr; 82(2):227-8. PubMed ID: 17106648
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of metastatic gastrointestinal stromal tumors with Imatinib: report of four cases].
    Garrido S M, Moneada M M, Tapia N G, Méndez O G, Galindo A H, Huete G A, Ibáñez A L, González S, Alvarez Z M.
    Rev Med Chil; 2007 Oct; 135(10):1327-32. PubMed ID: 18180842
    [Abstract] [Full Text] [Related]

  • 5. Anterior rectal wall gastrointestinal stromal tumor presenting clinically as prostatic mass.
    Madden JF, Burchette JL, Raj GV, Daly JT, Tannenbaum M.
    Urol Oncol; 2005 Oct; 23(4):268-72. PubMed ID: 16018942
    [Abstract] [Full Text] [Related]

  • 6. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
    Kobayashi K, Szklaruk J, Trent JC, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, Hicks ME, Gupta S.
    Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
    [Abstract] [Full Text] [Related]

  • 7. Giant gastrointestinal stromal tumor with remarkable preoperative response to imatinib mesylate.
    Stokes A, Herndon MD, Conforti AM.
    Am Surg; 2010 Aug; 76(8):903-4. PubMed ID: 20726426
    [No Abstract] [Full Text] [Related]

  • 8. Neoadjuvant imatinib in gastrointestinal stromal tumor of the rectum: report of a case.
    Lo SS, Papachristou GI, Finkelstein SD, Conroy WP, Schraut WH, Ramanathan RK.
    Dis Colon Rectum; 2005 Jun; 48(6):1316-9. PubMed ID: 15793646
    [Abstract] [Full Text] [Related]

  • 9. Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate.
    McAuliffe JC, Lazar AJ, Yang D, Steinert DM, Qiao W, Thall PF, Raymond AK, Benjamin RS, Trent JC.
    Clin Cancer Res; 2007 Nov 15; 13(22 Pt 1):6727-34. PubMed ID: 18006774
    [Abstract] [Full Text] [Related]

  • 10. Chronic myeloid leukemia and gastrointestinal stromal tumor: simultaneous presentation.
    Gollard R, Wierda W, Trent J.
    J Clin Oncol; 2007 Oct 10; 25(29):4682-3. PubMed ID: 17925564
    [No Abstract] [Full Text] [Related]

  • 11. CASE 3. Pathologic complete remission of metastatic gastrointestinal stromal tumor after imatinib mesylate.
    Chacón M, Roca E, Huertas E, Loria FS, Domenechini E.
    J Clin Oncol; 2005 Mar 01; 23(7):1580-2. PubMed ID: 15735135
    [No Abstract] [Full Text] [Related]

  • 12. Neoadjuvant treatment of rectal gastrointestinal stromal tumors with imatinib.
    Turner J, Batus M, Leslie W, Coogan C, Saclarides TJ.
    Am Surg; 2010 Aug 01; 76(8):E110-2. PubMed ID: 21513625
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of imatinib mesylate in patients with liver metastases from gastrointestinal stromal tumor failing intra-arterial hepatic chemotherapy with epirubicin.
    Fiorentini G, Bernardeschi P, De Simone M, Rossi S, Dentico P, Biancalani M, Scuderi S, Vaira M, Palomba A.
    J Exp Clin Cancer Res; 2003 Dec 01; 22(4 Suppl):13-6. PubMed ID: 16767899
    [No Abstract] [Full Text] [Related]

  • 14. Metastatic gastrointestinal stromal tumor with long-term response after treatment with concomitant radiotherapy and imatinib mesylate.
    Boruban C, Sencan O, Akmansu M, Atik ET, Ozbek S.
    Anticancer Drugs; 2007 Sep 01; 18(8):969-72. PubMed ID: 17667604
    [Abstract] [Full Text] [Related]

  • 15. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
    Rutkowski P, Debiec-Rychter M, Nowecki ZI, Wozniak A, Michej W, Limon J, Siedlecki JA, Jerzak Vel Dobosz A, Grzesiakowska U, Nasierowska-Guttmejer A, Sygut J, Nyckowski P, Krawczyk M, Ruka W.
    Med Sci Monit; 2007 Nov 01; 13(11):CR515-522. PubMed ID: 17968300
    [Abstract] [Full Text] [Related]

  • 16. Metastatic gastrointestinal stromal tumor and hypercalcemia in a patient with ulcerative colitis.
    Al-Moundhri MS, Al-Thahli K, Al-Kindy S, Salam J, Rao L.
    Saudi Med J; 2006 Oct 01; 27(10):1585-7. PubMed ID: 17013488
    [Abstract] [Full Text] [Related]

  • 17. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.
    Cohen MH, Farrell A, Justice R, Pazdur R.
    Oncologist; 2009 Feb 01; 14(2):174-80. PubMed ID: 19193781
    [Abstract] [Full Text] [Related]

  • 18. Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor.
    Santachiara R, Maffei R, Martinelli S, Arcari A, Piacentini F, Trabacchi E, Alfieri P, Ferrari A, Leonardi G, Luppi G, Longo G, Vallisa D, Marasca R, Torelli G.
    Haematologica; 2008 Aug 01; 93(8):1252-5. PubMed ID: 18519520
    [Abstract] [Full Text] [Related]

  • 19. Imatinib in gastrointestinal stromal tumor: does treatment duration matter?
    Adenis A, Penel N, Blay JY.
    Oncology; 2009 Aug 01; 77(3-4):157-61. PubMed ID: 19729974
    [Abstract] [Full Text] [Related]

  • 20. Imatinib mesylate treatment for advanced gastrointestinal stromal tumor: a pilot study focusing on patients experiencing sole liver metastasis after a prior radical resection.
    Zhu J, Wang Y, Hou M, Li HY, Zhang J.
    Oncology; 2007 Aug 01; 73(5-6):324-7. PubMed ID: 18497504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.